Limited Offer
Save 50% on book bundles
Immediately download your ebook while waiting for your print delivery. No promo code needed.
Medications for Older Persons
Recommendations, Harms, Evidence
- 1st Edition - June 1, 2025
- Editor: Roger Thomas
- Language: English
- Paperback ISBN:9 7 8 - 0 - 4 4 3 - 2 9 0 2 5 - 1
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 2 9 0 2 6 - 8
“Medications for Older Persons: Recommendations, Harms, Evidence” makes available in one complete resource the benefits of medications for older persons, harms if they are… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quote“Medications for Older Persons: Recommendations, Harms, Evidence” makes available in one complete resource the benefits of medications for older persons, harms if they are prescribed “potentially inappropriate medications” or have “potential prescribing omissions, and how many adverse events, rehospitalizations, and deaths are attributable to these medications. The book opens with a summary of medications that most benefit older patients, followed by the impact of older persons’ alcohol consumption, self-medication, and medication list accuracy and how these factors correlate to health outcomes. The remainder of the book is devoted to the assessment of medication groups focusing on Numbers Needed to Treat, Numbers Needed to Harm, and characteristics and numbers of adverse events. Medication groups covered include cardiovascular, central nervous system, renal, gastrointestinal, musculoskeletal, respiratory, endocrine, pain, and fall prevention. This text benefits researchers by providing a single source to identify groups of medications which require improvement in their benefit/harm profiles. Concurrently, it provides medications for each condition to guide older persons, their families, their physicians, pharmaceutical researchers, policy makers, and ministries of health in the health and well-being of the aging population.
• Conveys the benefit and harm profiles of medications for older persons
• Outlines which randomized controlled trials (RCTs) of medication effects have the lowest risk of bias and highest GRADE quality
• Discusses which randomized controlled trials (RCTs) have the longest and most complete follow up and accounts for the key risk factors and confounders
• Outlines which randomized controlled trials (RCTs) of medication effects have the lowest risk of bias and highest GRADE quality
• Discusses which randomized controlled trials (RCTs) have the longest and most complete follow up and accounts for the key risk factors and confounders
Researchers wishing to identify drug development possibilities with better benefit/harm profiles, clinicians caring for seniors in the community and in hospital, and health ministry funders.
Section 1. Recommendations for medications of older persons 1. A summary of medications that most benefit older patients: for clinicians, patients, their families, policy makers and health ministries 2. STOPP and American Geriatrics Society “potentially inappropriate medications" (PIMs) and START ”potential prescribing omissions” (PPOs) 3. The Calgary study of 295,706 admissions of older persons to four acute care hospitals 2013-2021 4. Adverse drug interactions in the Veterans Affairs Adverse Drug Event Reporting System 5. Pharmacokinetics and pharmacodynamics in older persons 6. Methods to identify adverse drug interactions and effects 7. How personalized medicine has changed senior patient outcomes at the Mayo Clinic and other centers Section 2. Older persons alcohol consumption, self-medication, and medication list accuracy 8. Older persons alcohol consumption 9. Self-medication and over the counter medications by older persons 10. The accuracy of recording medication lists, transferring lists between community practitioners and medical institutions, and the potential effects on the accuracy of assessing PIMs, PPOs and adverse medication events Section 3. Cardiovascular medications 11. Medications for hypertension 12. Medications for heart failure 13. Medications for arrhythmias 14. Medications for diuresis 15. Medications for coagulation Section 4. Central Nervous System medications 16. Medications for depression 17. Medications for anxiety 18. Medications for insomnia 19. Neuroleptic/antipsychotic medications 20. Avoiding medications with risks of delirium 21. Avoiding medications that augment dementia Section 5. Renal medication 22. Prescribing to reduce risks of renal insufficiency and failure Section 6. Gastrointestinal medications 23. Prescribing to reduce the risks of peptic ulcer disease, gastritis, and esophagitis and treat if present 24. Prescribing to reduce the risks of constipation or diarrhea Section 7. Musculoskeletal medications 25. Medications for arthritis 26. Medications for osteoporosis Section 8. Respiratory medications 27. Medications for COPD Section 9. Endocrine medications 28. Medications for diabetes Section 10. Pain medications 29. Non-opioid analgesics and opioids for seniors Section 11. Changing prescribing to prevent falls 30. Prescribing to prevent falls
- No. of pages: 300
- Language: English
- Edition: 1
- Published: June 1, 2025
- Imprint: Academic Press
- Paperback ISBN: 9780443290251
- eBook ISBN: 9780443290268
RT
Roger Thomas
Roger E. Thomas, MD, PhD, CCFP, FCFP, MRCGP, holds a BA Honors in Economics from Cambridge, PhD in Sociology from Yale, an MD from McMaster, and practiced as a rural physician 1979 in Newfoundland. Through 1980 to 1983, Dr. Thomas performed Medical Missionary work in Malawi. Through his career, Dr. Thomas has held faculty positions at East Carolina University, Toronto, Ottawa, Newfoundland, and currently is an Emeritus Professor of Family Medicine at the University of Calgary. He has 187 peer-reviewed publications and 108 abstracts on such topics as adverse medication events on seniors’ rehospitalization and death, prescribing for seniors using genomic data, evidence-based methods of deprescribing to reduce readmissions and death, total costs of seniors’ care and options to finance most needed care.
Affiliations and expertise
Emeritus Professor, University of Calgary